← Back
$IRD All transactions

Opus Genetics, Inc.

A

$ Value

$0

Shares

200,000

Price

$0

Filed

Sep 11

Insider

Name

Gagnon Robert E.

Title

Chief Financial Officer

CIK

0001504983

Roles

Officer

Transaction Details

Transaction Date

2025-09-10

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

200,000

Footnotes

Represents a grant of restricted stock units which vest with respect to 25% on September 2, 2026, with the remaining shares vesting in equal monthly installments on the last day of each full month over the next thirty-six (36) months, subject to the Reporting Person's continuing service. | The option will vest with respect to 25% on September 2, 2026, with the remaining shares vesting in equal monthly installments on the last day of each full month over the next thirty-six (36) months, subject to the Reporting Person's continuing service.

Filing Info

Accession No.

0000905148-25-003320

Form Type

4

Issuer CIK

0001228627

Gagnon Robert E.'s History

Date Ticker Type Value
2026-01-22 IRD A $0
2025-12-16 VSTM $3K
2025-09-16 VSTM $3K
2025-09-10 IRD A $0
2025-09-02 IRD A $0
2025-07-16 HBIO A $0
2025-06-16 VSTM $2K
2025-06-04 BBLG A $0
2025-05-22 VSTM A $0
2025-05-22 VSTM A $0

Other Insiders at IRD (90d)

Insider Bought Sold Last
YERXA BENJAMIN R
President
2026-01-22
SCHACHLE JOSEPH K
Chief Operating Officer
$20K 2026-03-16
MANUSO JAMES S J 2026-04-20
Rodgers Richard J 2026-04-20
Graves Adrienne L 2026-04-20
Benton Susan 2026-04-20
Gagnon Robert E.
Chief Financial Officer
2026-01-22
Gallagher Cam 2026-04-20
Ainsworth Sean 2026-04-20
Zaremba Rabourn Amy
Head of Fin. Quality Assurance
$15K 2026-03-16
Bennett Jean 2026-04-20
Magrath George
Chief Executive Officer
$127K 2026-03-16
Jayagopal Ashwath
Chief Scientific & Dev. Ofc.
$19K 2026-03-16